Abstract |
Increasing evidence implicates the aryl hydrocarbon receptor (AhR) as a possible regulator of mammary carcinogenesis. This study aims to clarify its prognostic impact in breast cancer (BC). Meta-analyses performed at the mRNA level demonstrated that the predictive value of AhR expression in BC depends on the lymph node (LN) status. AhR expression and sub-cellular location were then analyzed by immunohistochemistry in 302 primary BC samples. AhR was expressed in almost 90% of cases with a predominant nuclear location. Nuclear and cytoplasmic AhR levels were significantly correlated and associated with the expression of RIP140 (receptor-interacting protein of 140 kDa), an AhR transcriptional coregulator and target gene. Interestingly, total and nuclear AhR levels were only significantly correlated with short overall survival in node-negative patients. In this sub-group, total and nuclear AhR expression had an even stronger prognostic impact in patients with low RIP140-expressing tumors. Very interestingly, the total AhR prognostic value was also significant in luminal-like BCs and was an independent prognostic marker for LN-negative patients. Altogether, this study suggests that AhR is a marker of poor prognosis for patients with LN-negative luminal-like BCs, which warrants further evaluation.
|
Authors | Udo Jeschke, Xi Zhang, Christina Kuhn, Stéphan Jalaguier, Jacques Colinge, Kristina Pfender, Doris Mayr, Nina Ditsch, Nadia Harbeck, Sven Mahner, Sophie Sixou, Vincent Cavaillès |
Journal | International journal of molecular sciences
(Int J Mol Sci)
Vol. 20
Issue 5
(Feb 26 2019)
ISSN: 1422-0067 [Electronic] Switzerland |
PMID | 30813617
(Publication Type: Journal Article)
|
Chemical References |
- NRIP1 protein, human
- Nuclear Receptor Interacting Protein 1
- RNA, Messenger
- Receptors, Aryl Hydrocarbon
|
Topics |
- Breast Neoplasms
(genetics, metabolism, pathology)
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Lymph Nodes
(pathology)
- Nuclear Receptor Interacting Protein 1
(metabolism)
- Prognosis
- RNA, Messenger
(genetics, metabolism)
- Receptors, Aryl Hydrocarbon
(genetics, metabolism)
- Survival Analysis
|